cagrilintide, Placebo, cagrilintide, cagrilintide, cagrilintide
NN9833-8242
Phase 3 small_molecule active
Quick answer
cagrilintide, Placebo, cagrilintide, cagrilintide, cagrilintide for Overweight and obesity is a Phase 3 program (small_molecule) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Overweight and obesity
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active